RxDoctor Payments Data

Natalie St Clair

Psychiatric/Mental Health · Wichita, KSNPI 1326758467

Payments from drug & device makers

$1,833in general payments, 2019–2025

Across 65 payments — averaging $28.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$300
  • Teva Pharmaceuticals USA, Inc.$163
  • Idorsia Pharmaceuticals US Inc$158
  • Otsuka America Pharmaceutical, Inc.$157
  • Alkermes, Inc.$137
  • Novo Nordisk$125
  • plus $793 from 13 others

What the payments were for

  • Food & beverage$1,833100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,833 in reported general payments places this provider in the 70th percentile of 404 psychiatric/mental health providers in Kansas.

See all psychiatric/mental health providers in Kansas

Medicare billing

Part B allowed, 2024
$19,684
Medicare patients
41
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lamotrigine67$788
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$748
Venlafaxine Hcl ErVenlafaxine Hcl17$415
Duloxetine Hcl28$397
Ziprasidone Hcl13$395
Trazodone Hcl32$315
Escitalopram Oxalate40$257
Alprazolam34$229
Quetiapine Fumarate29$228
Zolpidem Tartrate35$215
Gabapentin16$207
Risperidone20$201
Clonazepam27$198
Sertraline Hcl37$194
Lorazepam27$180

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →